Ketokaps Max

Ketoprofen, the active ingredient in Ketokaps Max, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats mild to moderate pain and inflammatory conditions in adults. GNH USA supplies Ketokaps Max as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen is used to manage pain and inflammation in several musculoskeletal and rheumatic conditions.

- Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: alleviates inflammatory swelling and discomfort. - Musculoskeletal pain: provides analgesic relief for strains, sprains and backache.

Ketoprofen may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated liver enzymes. - Fluid retention causing mild edema.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe hypersensitivity reactions such as Stevens‑Johnson syndrome. - Renal impairment or acute kidney injury. - Hepatotoxicity with marked liver enzyme elevation. - Cardiovascular events including myocardial infarction. - Hematologic abnormalities like thrombocytopenia.

When prescribing Ketokaps Max, consider the following safety measures.

- Gastrointestinal risk: assess history of ulcers or bleeding before use. - Renal function: monitor kidney parameters in patients with existing renal disease. - Cardiovascular health: use cautiously in individuals with heart disease or hypertension. - Pregnancy and lactation: avoid unless clearly indicated by a healthcare professional. - Drug interactions: review concomitant medications for potential NSAID interactions. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Ketoprofen can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): amplified bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may enhance nephrotoxic potential. - Lithium: NSAIDs can raise lithium serum levels. - Methotrexate: reduced clearance leading to toxicity. - Corticosteroids: additive risk of gastrointestinal ulceration.